The sustained activation of CAR T cells, indicated by the expression of CD39 and CD69 along with our functional assays where tumour‐infiltrating lymphocytes (TILs) were isolated and assessed for effector cytokine production and cytotoxic activity, suggests ongoing antigenic stimulation and confirms that these cells retain their anti‐tumour functionality. The gene discussed is CD69; the disease is neoplasm.